Vinge advises Aspiro AB (publ) in connection with the public takeover offer from Project Panther Bidco Ltd, indirectly owned by  S. Carter Enterprises, LLC, which is controlled by Shawn Carter. All shareholders of Aspiro are offered SEK 1.05 in cash per share in Aspiro and the total value of the offer amounts to approx. MSEK 464. The acceptance period for the offer is expected to begin on or about 19 February 2015 and expire on or about 11 March 2015.

Arrow Electronics, Inc., based in Centennial, Colorado, USA, has launched a public takeover of Munich-based DATA MODUL Aktiengesellschaft Produktion und Vertrieb von elektronischen Systemen ("Data Modul AG"). Their subsidiary Arrow Central Europe Holding Munich GmbH, as the bidder, has announced a voluntary public takeover offer to acquire all shares in Data Modul AG at an offer price of EUR 27.50 per share. This corresponds to a premium of approximately 36% of the weighted average stock market price of the Data Modul shares during the last three months.

Shoosmiths has advised the shareholders of Rex Features, the largest independently owned photographic press agency in Europe, on its $33m sale to Shutterstock, Inc., a leading global provider of commercial digital imagery and music.

With Rex's editorial expertise and Shutterstock's technical prowess, the combined companies will bring a comprehensive offering to market across both editorial and commercial content.

Travers Smith LLP has advised private equity firm Exponent and other shareholders on the sale of Trainline to Kohlberg Kravis Roberts (KKR), a US-headquartered investment firm.

Trainline was launched in 1997 to sell rail tickets through the internet and call-centres and has since its establishment developed a robust IT platform with a strong focus on customer-driven innovation.  In 2006 Trainline was acquired by Exponent Private Equity from a consortium of shareholders including Virgin, Stagecoach and National Express transport groups.

In his function as the insolvency administrator, Mr. Stephan Ammann from PLUTA Rechtsanwalts GmbH has sold the brewery of Bürgerbräu Wolnzach AG to Urban Chestnut Brewing Company. The buyer who originates from the German region of Upper Bavaria has been living in the US for several years, where he successfully operates two breweries.

The purchase agreement was concluded with effect from 1 January 2015. The parties have agreed to maintain strict silence on the purchase price.

In the course of a capital increase, Travelport acquired a majority interest in travel-IT Beteiligungsgesellschaft. travel-IT was advised by Dr. Jörg aus der Fünten, partner at the Cologne office of commercial law firm Heuking Kühn Lüer Wojtek. The acquisition of 54.3 percent of the shares means Travelport's entry into the sale of tour operator services in Germany. The company aims to significantly increase its presence in the German travel market.
 

Japanese technology company Tsukishima Kikai Co. Ltd., Tokyo, acquired the majority shareholding in Bokela Ingenieurgesellschaft für Mechanische Verfahrenstechnik mbH and its subsidiaries at the end of 2014. Luther Rechtsanwalts - gesellschaft mbH advised the shareholders of the medium -
sized Karlsruhe company Bokela within the scope of the transaction.

Göteborg Energi has entered into an agreement with the muncipality of Lerum, whereby the municipality acquires Göteborg Energi AB’s shares in Lerum Energi AB. As a result of the agreement, the muncipality will be the sole shareholder of the company. The divestment of the shares in Lerum Energi is part of Göteborg Energi’s strategy to focus on the company’s core business in Gothenburg.

Travers Smith LLP is advising management on the sale of Eversholt Rail Group, one of the three leading rail rolling stock companies in the UK, to CK Investments, a company jointly owned by Cheung Kong Infrastructure and Cheung Kong (Holdings).

Olswang has advised the shareholders of Convergence Pharmaceuticals Ltd, a clinical biopharmaceutical company that specialises in chronic pain research and clinical treatment, on its acquisition by Biogen Idec, the world's oldest independent biotechnology company.